Cargando…

Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders

BACKGROUND: Cannabis is known to be associated with neuropsychiatric problems, but less is known about complications affecting other specified body systems. We report and analyze 35 recent remarkable cardiovascular complications following cannabis use. METHODS AND RESULTS: In France, serious cases o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jouanjus, Emilie, Lapeyre‐Mestre, Maryse, Micallef, Joelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187498/ https://www.ncbi.nlm.nih.gov/pubmed/24760961 http://dx.doi.org/10.1161/JAHA.113.000638

Ejemplares similares

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
por: Roussin, Anne, et al.
Publicado: (2022)

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021)

Addictovigilance contribution during COVID-19 epidemic and lockdown in France
por: Lapeyre-Mestre, Maryse, et al.
Publicado: (2020)

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database
por: Revol, Bruno, et al.
Publicado: (2022)

Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review
por: Gentile, Gaetan, et al.
Publicado: (2020)

Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
por: Soeiro, Thomas, et al.
Publicado: (2021)

Novel forms of injectable buprenorphine and French model of opioid use disorder treatment
por: Lapeyre-Mestre, Maryse
Publicado: (2020)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study
por: Moulis, Guillaume, et al.
Publicado: (2015)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders
por: Skalisky, Jordan, et al.
Publicado: (2017)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
por: Revet, Alexis, et al.
Publicado: (2020)

Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry
por: Palmaro, Aurore, et al.
Publicado: (2017)

Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France
por: Roussin, Anne, et al.
Publicado: (2013)

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
por: Lacroix, Clémence, et al.
Publicado: (2022)

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
por: Moulis, Guillaume, et al.
Publicado: (2012)

Assessment of the Accuracy of Using ICD-10 Codes to Identify Systemic Sclerosis
por: De Almeida Chaves, Sébastien, et al.
Publicado: (2020)

FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder
por: Kleinhans, Natalia M., et al.
Publicado: (2020)

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France
por: Pajiep, Marie, et al.
Publicado: (2021)

Population awareness of risks related to medicinal product use in Vientiane Capital, Lao PDR: a cross-sectional study for public health improvement in low and middle income countries
por: Caillet, Céline, et al.
Publicado: (2015)

Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
por: Moulis, Guillaume, et al.
Publicado: (2018)

A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases
por: Conte, Cécile, et al.
Publicado: (2018)

Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis‐related health problems among community cannabis users using social networking services
por: Masataka, Yuji, et al.
Publicado: (2022)

Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence
por: Moulin, Valerie, et al.
Publicado: (2018)

Comorbid alcohol and cannabis use disorders increase mortality in patients with eating disorders
por: Stryhn, L., et al.
Publicado: (2022)

Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study
por: Auger, Nathalie, et al.
Publicado: (2020)

Risk factors associated with the family care of people with serious mental illness
por: Carbonell, Ángela, et al.
Publicado: (2019)

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder
por: Feingold, Daniel, et al.
Publicado: (2021)

Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis‐related psychiatric disorders
por: Matsumoto, Toshihiko, et al.
Publicado: (2020)

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
por: Houghton, Richard, et al.
Publicado: (2019)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort Study
por: Fournier, Jean-Pascal, et al.
Publicado: (2012)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

The last 10 years: any changes in perceptions of the seriousness of alcohol, cannabis, and substance use in Canada?
por: Cunningham, John A., et al.
Publicado: (2019)

The Dutch SCORE-based risk charts seriously underestimate the risk of cardiovascular disease
por: Jørstad, H. T., et al.
Publicado: (2016)

Cannabis Use and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
por: Zhao, Jianqiang, et al.
Publicado: (2021)

Cannabis Use Frequency and Cannabis-Related Consequences in High-Risk Young Adults Across Cannabis Legalization
por: Doggett, Amanda, et al.
Publicado: (2023)

Ambulatory Medical Assistance - After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy
por: Compaci, Gisèle, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m2sep2mbpmsbqeql7h9q388ufe